Format

Send to

Choose Destination
J Cell Biochem. 2015 Nov;116(11):2610-9. doi: 10.1002/jcb.25208.

Anti-apoptotic effect of microRNA-30b in early phase of rat myocardial ischemia-reperfusion injury model.

Author information

1
Department of Cardiology, the Second Hospital of Jilin University, Changchun, 130041, P. R. China.
2
Department of Physiology, the College of Basic Medical Sciences of Jilin University, Changchun, 130021, P. R. China.
3
Department of Clinical Laboratory, the Second Hospital of Jilin University, Changchun, 130041, P. R. China.

Abstract

This study aimed to investigate the effect of microRNA-30b (miR-30b) in rat myocardial ischemic-reperfusion (I/R) injury model. We randomly divided Sprague-Dawley (SD) rats (n = 80) into five groups: 1) control group; 2) miR-30b group; 3) sham-operated group; 4) I/R group, and 5) I/R+miR-30b group. Real-time quantitative polymerase chain reaction, immunohistochemical staining and Western blot analysis were conducted. TUNEL assay was employed for testing cardiomyocyte apoptosis. Our results showed that miR-30b levels were down-regulated in I/R group and I/R + miR-30b group compared with sham-operated group (both P < 0.05). However, miR-30b level in I/R + miR-30b group was higher than I/R group (P < 0.05). Markedly, the apoptotic rate in I/R group showed highest in I/R group (P < 0.05). Additionally, the results illustrated that protein levels of Bcl-2, Bax, and caspase-3 were at higher levels in ischemic regions in I/R group, comparing to sham-operated group (all P < 0.05), while Bcl-2/Bax was reduced (P < 0.05). Bcl-2 level and Bcl-2/Bax were obviously increased in I/R + miR-30b group by comparison with I/R group, and expression levels of Bax and caspase-3 were down-regulated (all P < 0.05). We also found that in I/R + miR-30b group, KRAS level was apparently lower and p-AKT level was higher by comparing with I/R group (both P < 0.05). Our study indicated that miR-30b overexpression had anti-apoptotic effect on early phase of rat myocardial ischemia injury model through targeting KRAS and activating the Ras/Akt pathway.

KEYWORDS:

ANTI-APOPTOSIS; BAX; BCL-2; CASPASE-3; ISCHEMIC-REPERFUSION INJURY; KRAS; MICRORNA-30B; RAS/AKT PATHWAY

PMID:
25925903
DOI:
10.1002/jcb.25208
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center